Sarepta Therapeutics, Inc. SRPT Business Segments
| FY'25 | FY'24 | ||
|---|---|---|---|
| Revenue by Product | |||
| Elevidys | $898.73M-14.1% | $1.05B+422% | |
| Pmo Products | $965.57M-0.2% | $967.17M+2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Sarepta Therapeutics, Inc. break its business down?
- Sarepta Therapeutics, Inc. (SRPT) reports revenue by product across 2 parts — Elevidys and Pmo Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Sarepta Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Sarepta Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.